Table 1

Groups	C-group		TR-group		T-group
Groups	%	X±S.E	%	X±S.E	%	X±S.E
Mononucleated cells	64.17	641.7±15.06	77.66	776.6 ±9.68^a	55.16	551.6±91.77^a
Mononucleated cells+ 1 Mn	0.45	4.5 ± 1.92	0.95	9.5 ±2.84^a	6.16	61.6±6.66^a,b
Mononucleatedcells + 2 Mn	0.0	0.0 ±0.0	0.0	0.0 ±0.0	0.05	0.5±0.41
Binucleated cells	32.4	324.1 ± 11	9.62	96.2±12.77^a	17.60	176±32.44 ^a
Binucleated cells + 1 Mn	0.67	6.7 ± 0.26	0.60	6.03 ±1.32	2.21	22.1±6.01^a
Binucleated cells + 2 Mn	0.0	0.0 ± 0.0	0.04	0.40±0.33	0	0.0 ± 0.0
Nucleoplasmic bridges	0.16	1.6 ± 0.58	5.24	52.4±7.91^a	0.63	6.3 ±0.30^a,b
Trinucleated cells	1.01	10.10 ± 4.15	0.77	7.7±1.98	0.30	3.0 ± 1.28
Quadrinucleated cells	0.57	5.70 ± 2.39	0.24	2.40±1.13	0	0.0 ± 0.0
Apoptic cells	0.41	4.10 ± 0.83	2.10	21±2.68^a	2.06	20.6 ± 5.29^a
Necrotic cells	0.14	1.40 ± 0.60	2.77	27.7±9.03^a	15.83	158.3 ± 40.84^a,b
Results represents as mean ±standard error C-group: Control group TR: Treatment resistant group T: Treated group. *P < 0.05 a : P-value Significant when compared with C- group. b : P-value Significant when compared with TR-group.

Table 1: The incidence of mono-, bi-, tri-, quadrinucleated, apoptic,necrotic cells, and the frequencies of micronuclei and the nucleoplasmic bridges in CML and control groups.(counts in 1000
cells).